Showing results (61-70 of 138) with videos related to

Sort By:
Pageof 14
JAMA Dermatology|April 5, 2013
Improving management and patient care in lentigo maligna by mapping with in vivo confocal microscopyPascale Guitera, Fergal J Moloney, Scott W Menzies, et al.
Cancer|June 22, 2010
Prognostic factors in cutaneous desmoplastic melanoma: a study of 252 patientsRajmohan Murali, Helen M Shaw, Kenneth Lai, et al.
The Australasian Journal of Dermatology|September 16, 2021
A practical guide on the use of imiquimod cream to treat lentigo malignaPascale Guitera, Andreanne Waddell, Elizabeth Paton, et al.
Annals of Surgical Oncology|September 24, 2005
Melanoma metastases in regional lymph nodes are accurately detected by proton magnetic resonance spectroscopy of fine-needle aspirate biopsy samplesJonathan R Stretch, Ray Somorjai, Roger Bourne, et al.
Pathology|January 16, 2023
Representativeness of initial skin biopsies showing pure desmoplastic melanoma: implications for managementR V Rawson, I A Vergara, J R Stretch, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|January 18, 2015
Quality assurance in melanoma surgery: The evolving experience at a large tertiary referral centreR L Read, S Pasquali, L Haydu, et al.
Annals of Surgical Oncology|June 11, 2014
Primary melanoma location on the scalp is an important risk factor for brain metastasis: a study of 1,687 patients with cutaneous head and neck melanomasAnna M Huismans, Lauren E Haydu, Kerwin F Shannon, et al.
Annals of Surgical Oncology|December 21, 2012
The unpredictability of lymphatic drainage from the ear in melanoma patients, and its implications for managementHoward S Peach, Augustinus P T van der Ploeg, Lauren E Haydu, et al.
Annals of Surgical Oncology|July 17, 2008
Keystone flap reconstruction of primary melanoma excision defects of the leg-the end of the skin graft?Marc D Moncrieff, Felicity Bowen, John F Thompson, et al.
BMC Cancer|October 26, 2014
Adjuvant therapy with high dose vitamin D following primary treatment of melanoma at high risk of recurrence: a placebo controlled randomised phase II trial (ANZMTG 02.09 Mel-D)Robyn P M Saw, Bruce K Armstrong, Rebecca S Mason, et al.
Pageof 14